Compare Ginkgo Bioworks Holdings Inc (DNA) vs Live Nation Entertainment, Inc. (LYV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Live Nation Entertainment, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Live Nation Entertainment, Inc. trades at $170.33 (market cap $39.92B). The key difference: Live Nation Entertainment, Inc. is far larger — about 52.3× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is more actively traded (3,204,177 versus 1,982,609). Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Live Nation Entertainment, Inc. for 72 Days on average.
| DNA | LYV | |
|---|---|---|
Market Cap | $763.64M | $39.92B |
Volume | 3,204,177 | 1,982,609 |
Sector | Health | Media |
52-Week High | $15.83 | $188.46 |
52-Week Low | $5.48 | $125.61 |
Typical Hold Time | 7 Days | 72 Days |
Enterprise Value | $865.59M | $42.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
Live Nation Entertainment (LYV) trades at $171.34, up 0.29% with a bullish technical signal and strong analyst support. The company reported mixed Q2 2026 earnings with a beat on EPS but faces valuation concerns with a P/E of 117.49 and negative ROE of -116.65%. Recent news highlights strong consumer demand for live events and strategic partnerships, though insider selling and regulatory scrutiny present headwinds.
The outlook remains positive with 87% analyst buy ratings and a $208.18 price target, representing 21% upside. Key risks include high debt levels, margin pressure, and ongoing regulatory challenges. Revenue growth continues with 2026 projections of $26.3B, but profitability metrics need improvement for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →
